Altimmune Inc (ALT)

NASDAQ HEALTHCARE
$2.63 -4.01% RSI 29 Oversold Add Alert

Moving Averages

SMA 200
$4.14
Price below

Company Profile

Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$421.54M
P/E Ratio
None
EPS
$-1
Beta
0.338
Dividend Yield
0.00%
52-Week High
$7.73
52-Week Low
$2.87

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 11, 2026 at 7:16 AM EDT

Track ALT for free

Get e-mail RSI alerts when Altimmune Inc enters oversold or overbought territory. Free forever.

Add Alert